Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysisNicholas A. Vitanza, Julie R. Park, Adam Johnson et al.|Nature Medicine|2021Cited by 319
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and SafetyNicholas A. Vitanza, Julie R. Park, Erin Crotty et al.|Cancer Discovery|2022Cited by 277
Early Clinical Experience of CD19 x CD22 Dual Specific CAR T Cells for Enhanced Anti-Leukemic Targeting of Acute Lymphoblastic LeukemiaRebecca Gardner, Michael C. Jensen, Colleen Annesley et al.|Blood|2018Cited by 65
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid TumorsNavin Pinto, Julie R. Park, Catherine M. Albert et al.|Journal of Clinical Oncology|2024Cited by 46
Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safetyNicholas A. Vitanza, Julie R. Park, Rebecca Ronsley et al.|Neoplasia|2023Cited by 35